Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (461-470 of 487) with videos related to

Pageof 49
Sort By:
Blood|May 9, 2012
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopeniaVivek L Patel, Matthieu Mahévas, Soo Y Lee, et al.
Blood|July 1, 1996
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of HematologyJ N George, S H Woolf, G E Raskob, et al.
Blood Advances|August 5, 2025
Safety and Efficacy of Daratumumab in Immune ThrombocytopeniaGalina Tsykunova, Pål Andre Holme, Hoa Thi Thyuet Tran, et al.
British Journal of Haematology|March 18, 2026
A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndromeJorge N Ruiz Lopez, Lipei Shao, Debbie Jiang, et al.
Blood|January 31, 2013
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working GroupFrancesco Rodeghiero, Marc Michel, Terry Gernsheimer, et al.
American Journal of Hematology|April 6, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 TrialNichola Cooper, Catherine M Broome, Yoshitaka Miyakawa, et al.
British Journal of Haematology|July 22, 2014
A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?Dana N LeVine, Adam J Birkenheuer, Marjory B Brooks, et al.
Blood|November 14, 2008
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupFrancesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, et al.
Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.
American Journal of Hematology|April 8, 2017
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopeniaDavid J Kuter, Barbara A Konkle, Taye H Hamza, et al.
Pageof 49

Showing results (461-470 of 487) with videos related to

Sort By:
Pageof 49
Blood|May 9, 2012
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopeniaVivek L Patel, Matthieu Mahévas, Soo Y Lee, et al.
Blood|July 1, 1996
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of HematologyJ N George, S H Woolf, G E Raskob, et al.
Blood Advances|August 5, 2025
Safety and Efficacy of Daratumumab in Immune ThrombocytopeniaGalina Tsykunova, Pål Andre Holme, Hoa Thi Thyuet Tran, et al.
British Journal of Haematology|March 18, 2026
A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndromeJorge N Ruiz Lopez, Lipei Shao, Debbie Jiang, et al.
Blood|January 31, 2013
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working GroupFrancesco Rodeghiero, Marc Michel, Terry Gernsheimer, et al.
American Journal of Hematology|April 6, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 TrialNichola Cooper, Catherine M Broome, Yoshitaka Miyakawa, et al.
British Journal of Haematology|July 22, 2014
A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?Dana N LeVine, Adam J Birkenheuer, Marjory B Brooks, et al.
Blood|November 14, 2008
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupFrancesco Rodeghiero, Roberto Stasi, Terry Gernsheimer, et al.
Lancet (London, England)|August 2, 2015
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trialJohn D Grainger, Franco Locatelli, Thirachit Chotsampancharoen, et al.
American Journal of Hematology|April 8, 2017
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopeniaDavid J Kuter, Barbara A Konkle, Taye H Hamza, et al.
Pageof 49